D-Methionine and cisplatin ototoxicity in the guinea pig:: D-methionine influences cisplatin pharmacokinetics

被引:64
作者
Ekborn, A [1 ]
Laurell, G
Johnström, P
Wallin, I
Eksborg, S
Ehrsson, H
机构
[1] Karolinska Hosp, Dept Otorhinolaryngol Head & Neck Surg, SE-17176 Stockholm, Sweden
[2] Karolinska Pharm, SE-17176 Stockholm, Sweden
关键词
cisplatin; D-Methionine; pharmacokinetics; ototoxicity; nephrotoxicity; positron emission tomography;
D O I
10.1016/S0378-5955(02)00277-0
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
D-Methionine has recently been advocated as a protectant against cisplatin toxicity. The Use Of Systemic D-methionine as a protector was studied in 58 guinea pigs, Kinetics and distribution of [(CH3)-C-11]D-methionine was analysed by positron emission tomography. Cisplatin and the monohydrated complex of cisplatin was quantified in blood ultrafiltrate using reversed-phase liquid chromatography with post-column derivatisation, Administration of 300 mg/kg Of D-methionine caused a 30%, decrease in the area under the concentration-time curve (AUC) of cisplatin. The toxic effect of cisplatin was studied after dose adjustment of cisplatin. i.e. with similar cisplatin AUC in the group receiving D-Methionine and the saline control group. A significant ototoxic effect, measured as difference in pre- and 96 h post-treatment electrophysiological hearing threshold (auditory brainstem response). was observed at stimulus frequencies of 30 and 20 kHz. There was no difference between the groups in the extent of threshold shift. Quantitative outer hair cell counts showed a similar loss of cells in the two groups. All animals had a significant increase in plasma-creatinine but there was no difference between the groups. The results indicate that protection from cisplatin ototoxicity by systemic D-methionine can be explained by a lowered systemic exposure to the drug. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 34 条
  • [1] SOME PROCEDURES TO REDUCE CIS-PLATINUM TOXICITY REDUCE ANTITUMOUR ACTIVITY
    AAMDAL, S
    FODSTAD, O
    PIHL, A
    [J]. CANCER TREATMENT REVIEWS, 1987, 14 (3-4) : 389 - 395
  • [2] EXACERBATION OF CISPLATIN-INDUCED NEPHROTOXICITY BY METHIONINE
    ALDEN, WW
    REPTA, AJ
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1984, 48 (01) : 121 - 124
  • [3] Pharmacokinetics of cisplatin and its monohydrated complex in humans
    Andersson, A
    Fagerberg, J
    Lewensohn, R
    Ehrsson, H
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (08) : 824 - 827
  • [4] DETERMINATION OF CISPLATIN AND CIS-DIAMINEAQUA-CHLOROPLATINUM(II) ION BY LIQUID-CHROMATOGRAPHY USING POSTCOLUMN DERIVATIZATION WITH DIETHYLDITHIOCARBAMATE
    ANDERSSON, A
    EHRSSON, H
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 652 (02): : 203 - 210
  • [5] ANDREOTTI PE, 1995, CANCER RES, V55, P5276
  • [6] Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
    Bokemeyer, C
    Berger, CC
    Hartmann, JT
    Kollmannsberger, C
    Schmoll, HJ
    Kuczyk, MA
    Kanz, L
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1355 - 1362
  • [7] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
    BOXENBAU.HG
    RIEGELMA.S
    ELASHOFF, RM
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
  • [8] PARTIAL REVERSIBILITY OF CISPLATIN NEPHROTOXICITY IN CHILDREN
    BROCK, PR
    KOLIOUSKAS, DE
    BARRATT, TM
    YEOMANS, E
    PRITCHARD, J
    [J]. JOURNAL OF PEDIATRICS, 1991, 118 (04) : 531 - 534
  • [9] D-Methionine provides excellent protection from cisplatin ototoxicity in the rat
    Campbell, KCM
    Rybak, LP
    Meech, RP
    Hughes, L
    [J]. HEARING RESEARCH, 1996, 102 (1-2) : 90 - 98
  • [10] MORPHOLOGICAL AND FUNCTIONAL PRESERVATION OF THE OUTER HAIR-CELLS FROM NOISE TRAUMA BY SOUND CONDITIONING
    CANLON, B
    FRANSSON, A
    [J]. HEARING RESEARCH, 1995, 84 (1-2) : 112 - 124